Sp1 acts as a repressor of TERT in cancer cells by forming a complex with Sp3, while in Kaposi sarcoma associated herpes virus (KSHV), Sp1 becomes an activator via interactions with latency-associated antigen—briefly known as LANA [45,46,47]. Here, TERT is linked to cancer.